MAENG, CHEOL YOUNG,맹철영,JANG, YOUNG KOO,장용구,CHA, SU BONG,차수봉,SHIN, HYE WON,신혜원,JOUNG, CHAN MI,정찬미,CHA, HWA RYUN,차화륜,YI, EUN JUNG,이은정
申请号：
KR1020120008536
公开号：
KR1020120087852A
申请日:
2012.01.27
申请国别(地区):
KR
年份:
2012
代理人:
摘要：
PURPOSE: A pharmaceutical composition containing pyridone derivative compounds, or pharmaceutically acceptable salt, isomer, solvate, or hydrate thereof is provided to effectively prevent or treat cognitive disorder-associated diseases. CONSTITUTION: A pyridone derivative compound or pharmaceutically acceptable salt, isomer, solvate, or hydrate thereof is denoted by chemical formula I or II. In chemical formulas I or II, A is halo, amino, C1-C6 alkyl, C2-C6 alkinyl, C3-C7 cyclo alkyl, C1-C6 alkoxy, C6-C12 aralkoxy, C6-C12 aryl oxy, C1-C6 alkyl thio, C6-C12 aralkyl thio, C6-C12 aryl thio, C1-C6 alkyl sulfonyl or C2-C10 heteroaryl-substituted C6-C12 aryl. A pharmaceutical composition for preventing or treating cognitive disorder contains therapeutically effective amount of pyridine derivative compounds, or pharmaceutically acceptable salt, isomer, solvate, or hydrate thereof.피리돈 유도체 화합물, 이의 약학적으로 허용가능한 염, 이성질체, 용매화물 또는 수화물에 관한 것이다. 일 구체예에 따른 약학적 조성물에 의하면, 인지 장애와 관련된 질환을 효과적으로 예방 또는 치료할 수 있다.
